News

What's new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

AGE Reader approved as medical device in Mexico

The AGE Reader has received its market approval from COFEPRIS in Mexico. “We have been working on
this for a long time with our partner PDE in Mexico, says Bart van den Berg, CEO of Diagnoptics.
Perseverance was needed because the severe hit by Covid caused a significant delay.” PDE, or
Prevención Y Detección Especializada, is specialized in early detection of disease like breast cancer,
cardiovascular disease and diabetes. The availability of the AGE Reader in Mexico will certainly improve
the prevention from these devastating diseases. The introduction of the AGE Reader and education of
the medical society has already started, so people in Mexico may expect the opportunity to be checked
on their health risks soon.

The AGE Reader provides an immediate cardiovascular risk prediction in 12 Seconds. It has been
designed for patient friendly diagnosis and allows doctors to practice personalized care and prevent
disease (progression). As an optical measurement of the skin is used, it is noninvasive and provides an
alternative to cost-intensive laboratory tests. The method is convenient, easy to use and extensively
validated.

If you would like to receive further information regarding the AGE Reader, please do not hesitate to
contact us. If you are based in Mexico, please contact PDE directly on contact PDE.

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.